Nanotechnology in the management of cervical cancer

Abstract

Cervical cancer is a major disease with high mortality. All cervical cancers are caused by infection with human papillomaviruses (HPV). Although preventive vaccines for cervical cancer are successful, treatment of cervical cancer is far less satisfactory because of multidrug resistance and side effects. In this review, we summarize the recent application of nanotechnology to the diagnosis and treatment of cervical cancer as well as the development of HPV vaccines. Early detection of cervical cancer enables tumours to be efficiently removed by surgical procedures, leading to increased survival rate. The current method of detecting cervical cancer by Pap smear can only achieve 50% sensitivity, whereas nanotechnology has been used to detect HPVs with greatly improved sensitivity. In cervical cancer treatment, nanotechnology has been used for the delivery of anticancer drugs to increase treatment efficacy and decrease side effects. Nanodelivery of HPV preventive and therapeutic vaccines has also been investigated to increase vaccine efficacy. Overall, these developments suggest that nanoparticle-based vaccine may become the most effective way to prevent and treat cervical cancer, assisted or combined with some other nanotechnology-based therapy.

Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines

“…Combination of liposomes for immunotherapy with other therapeutic strategies, such as chemotherapy [particles loaded with doxorubicin, cisplatin (41,42), or paclitaxel (43)] or photodynamic therapy (PDT) can be expected to lead to better than the reported in literature result (44).…”

Can Nanotechnology help push the Limit for Early Cancer Diagnostics?

“…Nanotechnology also offers tremendous opportunities in diagnosis of cervical cancer compared to commonly used techniques of cytology and HPV detection, which are challenged due to the lack of sensitivity, especially in detecting pre-invasive cervical cancers. The detection of HPV genes could help diagnose cervical cancer at a very early stage and thus enhance cancer treatment efficacy [8].…”

Bioconjugation of AuNPs with HPV 16/18 E6 antibody through physical adsorption technique

“…Early cervical cancer diagnostics has been improved by application of nanotechnologies (16). For example; the ultra-bright fluorescent mesoporous silica nanoparticle to detect folate (Fa) receptors on cervical cells surface.…”